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Edited by Lukas HuberAbstract Taxol treatment of HeLa cells resulted in a transient
recruitment of Caveolin-1 to the cell surface followed by inter-
nalization. Interestingly, 20 min after 10-deacetylbaccatinIII
(10-DAB) treatment, the caveolae displayed faster kiss and
run dynamics while BaccatinIII (BacIII) did not induce any
change. Sustained phosphorylation of Caveolin-1 is observed
upon treatment and between Taxol and 10-DAB, the former
shows phosphorylated Raf-1, ERK1/2 and hyperphosphorylated
Bcl-2 while the later showed much less magnitude of the same.
BacIII treatment did not induce phosphorylation of Raf-1 or
Bcl-2. It is possible that Taxol might act on multiple targets
and the side chain may be crucial.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Taxol has shown considerable promise as an eﬀective anti-
tumor drug against various human cancers [1]. With the
development of the chemical method(s) for the synthesis of
the Taxol and its derivatives it became clear that it is the side
chain which apparently plays a signiﬁcant role in its cytotoxic
activity [2]. Our aim of the present study was to understand the
role of the side chain of Taxol with respect to its functionality.
Hence, we compared Taxol, 10-deacetylbaccatinIII (10-DAB)
and BaccatinIII (BacIII) which diﬀer only in the side chain.
All three drugs have been shown to induce apoptosis but might
follow apparently diﬀerent pathways [3]. Recently it has been
reported that Taxol induces expression of Caveolin-1, a
marker protein of the caveolae, in MCF-7 cells and that the
Caveolin-1 phosphorylation at tyrosine-14 is necessary to en-
hance Taxol mediated cytotoxicity [4]. Considering that Taxol
is known to bind to microtubules and not caveolae per se, the
requirement and role of Caveolin-1 is not clear. Moreover,
Caveolin-1, as part of caveolae, is not an entirely static entity
as the caveolae undergo a continuous cycle of kiss and run*Corresponding author. Fax: +91 20 25692259.
E-mail address: mvks@nccs.res.in (M.V. Krishnasastry).
1Authors made equal contribution.
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doi:10.1016/j.febslet.2008.09.029(K&R) dynamics with the plasma membrane [5]. In view of
the dynamic nature of caveolae, we examined the distribution
and change in dynamics of Caveolin-1 (or caveolae) in context
with the cytotoxicity in HeLa cells expressing GFP-Caveolin-1
by total internal reﬂection ﬂuorescence microscopy (TIRFM).2. Materials and methods
Taxol, BacIII and 10-DAB, purchased from Sigma Chemical Co.,
USA, which were dissolved in dimethylsulfoxide (DMSO) to 1 mg/ml
stock solution.
2.1. Cell culture and transfection with GFP-Caveolin-1
HeLa cells were cultured in DMEM medium supplemented with
10% (v/v) fetal calf serum and penicillin and streptomycin. All drug
treatments were done at 60–70% cell conﬂuency. HeLa cells were trans-
fected with GFP-Caveolin-1 construct (given by Dr. A. Helenius) after
seeding them at a density of 2 · 105 cells/ml in 35 mm culture dish with
fuGENE 6 kit using 1 lg of plasmid at 6:1 reagent to plasmid ratio.
After 6 h of transfection, the medium was replaced with complete
medium.
2.2. TIRFM
The cover slip containing the HeLa cells transfected with
GFP-Caveolin-1 construct after 12 h were mounted in an Atto cham-
ber containing DMEM without phenol red and 1 mg/ml BSA. The to-
tal internal reﬂection angle was adjusted to observe the dynamics of
GFP-Caveolin-1 in regions of the cells in an Olympus IX-81 micro-
scope equipped with an Argon laser (488 nm line). All recordings were
performed with 100·-TIRFM (1.45NA) objective with Cascade 512B
camera at 10 Hz at 10 ms exposure time for about 90 frames for each
recording. The data were recorded before treatment and after the indi-
cated drug treatment. All the videos submitted were recorded with 25
frames per second.2.3. Confocal microscopy
HeLa cells, after 12 h of transfection, were treated with Taxol or
BacIII or 10-DAB for a given time followed by washing with PBS.
Cells were then ﬁxed with 3.7% paraformaldehyde (pH 7.4) in PBS,
pH 7.4, for 10 min and permeabilized with 0.1% Triton X-100 for
20 min. Non-speciﬁc binding was blocked by pretreatment with 3%
BSA in PBS for 30 min. The cells were then incubated with anti-Tubu-
lin antibody (at 1:1000 dilution) for 1 h at room temperature followed
by washing and incubation with anti-mouse Alexa-568 secondary
antibody (1:1000). The cells were then visualized in Zeiss LSM 510
Confocal microscope. Fluorescence emission was detected in 0.5 lm
optical sections.
2.4. MTT assay
To assay the viability of cell after treatment with Taxol, BacIII or
10-DAB treatment, HeLa cells were seeded at a density of 5 · 103 cells
per well in a 96-well plate and treated with various concentrations ofblished by Elsevier B.V. All rights reserved.
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end of the treatment, the media was removed and 50 ll of MTT
(1 mg/ml) in DMEM (without phenol red) was added to each well
and incubated for another 4 h at 37 C. Formazan crystals were solub-
lized in 50 ll of iso-propanol with shaking at room temperature for
10 min. Absorbance was measured at 570 nm using 630 nm ﬁlter.
Absorbance given by cells treated with DMSO was taken as 100%
viability.
2.5. Immunoblotting
HeLa cells (2.0 · 105) were seeded in six well plates till they attained
70% conﬂuency. Cells were treated with the three drugs for indicated
times. The wells were washed with PBS and the cells were scraped from
the wells to recover the cell pellet by centrifugation. The cells were then
resuspended in lysis buﬀer containing protease inhibitors (10 lg/ml
leupeptin, 2 mM phenylmethylsulfonylﬂuoride (PMSF) and 2 mM
Na3VO4). Equal amount of protein was loaded on SDS–PAGE
(10–15%) and electrophoresed proteins were transferred to a nitrocel-
lulose membrane using Tris–Glycine pH 8.0 and were probed with
anti-phosphotyrosine (PY20) (Santa Cruz, sc-508), p-Raf-1 (cell signal-
ing, #9421), p-ERK1/2 (Santa Cruz, sc-7383), ERK1/2 (Santa Cruz,
sc-94), p-P38 (Santa Cruz, sc-7973), Bcl-2 (Santa Cruz, sc-7382),
anti-mouse IgG, HRP-linked antibody (cell signaling, #7076), anti-
rabbit IgG, HRP-linked antibody (cell signaling, #7074), HRP detec-
tion reagent, LumiGLO reagent and peroxide (cell signaling #7003).Fig. 1. (A) Trypanblue staining of HeLa cells post drug treatment:
Viable cells after treatment with drugs (1 h) was assayed by trypan blue
staining and the percentage of unstained cells were plotted. Data
shown are in both panels are an average of three independent
experiments. (B) Cell viability assay by MTT. HeLa cells were seeded
at a density of 5 · 103 cells per well into 96-well plate and incubated
with various concentrations of Taxol, 10-DAB and BacIII ranging
from 10 lM to 0.15 lM for 48 h and then MTT was added.
Absorbance of DMSO treated cells was taken as 100% and the viable
cells for drug treatment were plotted.3. Results and discussion
The aim of the present work is to understand the role and
dynamics of Caveolin-1 in Taxol induced cytotoxicity of
mammalian cells. HeLa cells have shown both very high and
moderate expression for GFP-Caveolin-1 and for the present
work, we selected the cells that moderately expressed GFP-
Caveolin-1. Firstly, treatment with the three drugs did not in-
duce any membrane damage within 1 h of their addition as
seen by trypan blue staining of drug treated cells. The number
of viable cells remained same in comparison to untreated cells
as shown in Fig. 1A. There are several reports indicating that
Taxol, 10-DAB and BacIII induce cell death by apoptosis
[3,6–8]. The data is Fig. 1B is consistent with the published lit-
erature which shows that the HeLa cells exhibited susceptibil-
ity to all the three drugs. Diﬀerent concentrations, starting
from 0.15 lM to 10 lM for 48 h, have clear cytotoxic aﬀect
on HeLa cells. It is interesting to see that at highest concentra-
tion of Taxol (10 lM), BacIII and 10-DAB showed almost
same percentage of cell death (around 80%), as compared with
the solvent control (DMSO), but at lower concentrations
(5–0.15 lM) only Taxol was eﬀective. Moreover, after 24 h
of treatment, only Taxol was cytotoxic to HeLa cells (data
not shown).
Caveolin-1 of caveolae is not entirely a static entity in
mammalian cell membranes as the caveolae undergo K&R
dynamics with the plasma membrane. In view of the K&R
dynamics of caveolae, we have employed total internal reﬂec-
tion ﬂuorescence microscopy, which is an excellent tool for
the study of events that occur at/beneath plasma membrane.
It was interesting to see that Taxol and 10-DAB elicited dis-
tinct behavior of the GFP-Caveolin-1 dynamics [videos SV1–
SV5 and Fig. 2A (IV–IX)]. The HeLa cells expressing GFP-
Caveolin-1, before treatment, exhibited a characteristic K&R
events which are identical to the observations reported by
Pelkmans and Zerial (see video SV1 and Supplementary Video
1 in Ref. [5]). With the addition of Taxol (5 lM) there was an
immediate cell surface recruitment of GFP-Caveolin-1
(Fig. 2A-V, and video SV2). One could clearly see the forma-tion of several new clusters of GFP-Caveolin-1 at the cell sur-
face in comparison to untreated cells (videos SV2 vs. SV1;
Fig. 2A-V vs. 2A–IV). However, after 1 h of Taxol (5 lM)
treatment there was a signiﬁcant withdrawal of the GFP-Cave-
olin-1 from the cell surface (Fig. 2A-VI, and video SV3). While
no such immediate cell surface recruitment was seen in case of
10-DAB (Fig. 2A-VIII) and BacIII (Fig. 2A-XI). A very inter-
esting observation was made incase of 10-DAB (5 lM) where a
several fold increase in the radial velocity of the GFP-Caveo-
lin-1 was observed after 20 min of addition (video SV5), as
compared to the movement of the GFP-Caveolin-1 before
addition of the 10-DAB (video SV4). The motion was analyzed
by plotting the velocity histograms of Caveolae spots of several
videos. In brief, the velocity of each caveolae spot seen in vid-
eos before and after treatment was measured by obtaining the
net distance traveled by the caveolae spot divided by the time
taken to reach the end point of observation. The representative
velocity histogram, shown in Fig. 2B, highlights the normal
Fig. 2. (A) TIRFM images of GFP-Caveolin-1 on HeLa cell basal membrane: Distribution pattern of GFP-Caveolin-1 on the cell surface of the live
HeLa cell was recorded by TIRF microscope. Still frame images from the videos showing the distributions of GFP-Caveolin-1 before and after
treatment of DMSO, Taxol, 10-DAB and BacIII (5 lM each). Videos were acquired with Cascade 512B camera for a minimum of 90 frames (4 s) or
more. Full videos have been provided as supplementary material for the panels marked with SV1–SV5. Data, shown in all panels, is one of the three
independent experiments. (B) and (C) Velocity Histograms of GFP-Caveolin-1: The motion of caveolae was analyzed by obtaining the total distance,
in pixels, moved by a caveolae vesicle in X- and Y- dimensions. Brieﬂy, we have collected the video recordings of 90 or more consecutive frames over a
period of 3–4 s at 25 frames per second. The centroid (i.e. X- and Y- coordinates) of each caveolae spot was obtained from ImageJ software and
exported to excel spread sheet. The net distance (the sum of the distances (X 1,Y 1) to (X 2,Y 2) to (Xn, Y n) from frame 1–n) moved by the caveolae spot
in pixel values were calculated and converted into nanometers after taking the magniﬁcation factors of the microscope into consideration. To obtain
the velocity of a given caveolae spot, the net distance traveled by the caveolae spot was divided with the total time (in second) taken by that caveolae
frame 1–n. These velocity values are used as bin values (X-axis) and the number of caveolae that belonged to that bin value or frequency (Y-axis) were
plotted as a histogram. The symbols open circles (s) represent before 10-DAb treatment in 2B and 2 C and ﬁlled circles () after 10-DAB treatment
in 2C. For example the number of caveolae that moved less than or equal to 1000 nm is one set of bin and Y-axis points. The microscope
magniﬁcation factor is 105 nm/1 pixel. It is assumed that the caveolae spot seen in frame 2 for a given X-, Y-coordinates is same as that seen in frame
1. In view of this assumption, any spot that exhibited large mobility i.e. >4 pixels between two successive frames was not included for calculation as it
may represent noise or spurious movement.
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lation for 10-DAB treated caveolae shown in Fig. 2C, exhib-
ited the velocity peaked at 5 lm/s while the net percentage
of the higher velocity caveolae have gone up after treatment.
No signiﬁcant change was observed either in the distribution
or in the mobility of the GFP-Caveolin-1 with DMSO alone
indicating that the dramatic mobility of 10-DAB treated cave-
olae is due to drug only (solvent control Fig. 2A, I–III). How-
ever, with BacIII (5 lM), neither an immediate cell surface
recruitment (seen in case of Taxol) nor an increase in the radial
velocity after 20 min (like 10-DAB treatment) of the GFP-
Caveolin-1 was observed but only similarity with other two
drugs was the surface withdrawal of the GFP-Caveolin-1 with-
in an hour of the treatment (Fig. 2A, X–XII). Under these con-
ditions, we have not observed any re-appearance of the
caveolae at the cell surface.
The dynamics of the GFP-Caveolin-1 by TIRFM indicate
that within an hour of the treatment with Taxol, BacIII and10-DAB there was a signiﬁcant withdrawal of the cell surface
GFP-Caveolin-1. This withdrawal may indicate an internaliza-
tion of GFP-Caveolin-1. Hence, we were interested in locating
the GFP-Caveolin-1 throughout the cell. In order to conﬁrm
the internalization of GFP-Caveolin-1 with Taxol, 10-DAB
and BacIII treatment we analyzed z-stacks sections at an inter-
val of 0.5 lm of the diﬀerent regions by Confocal microscopy
before and after drug treatment. As seen in Fig. 3, we observed
a complete internalization of GFP-Caveolin-1 after 1 h treat-
ment with these three drugs as compared to control (Control,
Fig. 3, top row) or the solvent control (DMSO, Fig. 3, second
row) which show most of the GFP-Caveolin-1 was localized at
the membrane. These Confocal studies further conﬁrm the
internalization of the GFP-Caveolin-1 upon treatment with
these drugs.
Recent studies have shown that phosphorylation of
Caveolin-1 was essential for its internalization [9]. Since we
have seen the withdrawal of GFP-Caveolin-1 by TIRFM
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microscopy we examined the phosphorylation status of GFP-
Caveolin-1. The data shown in Fig. 4A clearly shows an in-
crease in phosphorylation of Caveolin-1 after 1 h of treatment
with Taxol, 10-DAB and BacIII accompanied by an increase in
the phosphorylation of p38. The status of total tyrosine
phosphorylated proteins has not displayed any dramatic diﬀer-
ences upon the Taxol treatment within 1 h except for the pro-
tein at 38 kDa. Moreover, Taxol treatment has resulted in an
increase in the phosphorylation of Caveolin-1 within 1 h
(Fig. 4B).
Further we were also interested in examining whether there
are any diﬀerences in the signaling pathways with these three
compounds that lead to the cell death. It has been reported
that Taxol follows the p-Raf-1, ERK pathway. Hence, we
examined the phosphorylation of Raf-1 and ERK1/2 and
found that the phosphorylation of Raf-1 and ERK1/2 in-
creases with Taxol and 10-DAB treatment but there was no
signiﬁcant change in phosphorylation of the same with BacIII
(Fig. 4A) indicating of diﬀerent pathways [10–13]. Moreover,
Bcl-2, which gets hyperphosphorylated within 3 h of TaxolFig. 3. Internalization of GFP-Caveolin-1 as examined by confocal
imaging: HeLa cells, 24 h after transfection, were treated with DMSO
(vector control), Taxol, 10-DAB and BacIII with 5 lM each for 1 h
and then processed for Confocal imaging. Blue panel show the nucleus
staining with DAPI, green panel show the distribution pattern of GFP-
Caveolin-1. In control (untreated cells), DMSO (solvent controls)
GFP-Caveolin-1 is mainly localized on the membrane but treatment
with Taxol, 10-DAB and BacIII (5 lM each) for 1 h shows signiﬁcant
cytoplasmic localization. Merged images are shown in last panel. Data,
shown in all panels, is one of the three independent experiments.treatment, was also found to diﬀer between the three drugs
in the time frame observed. The data in Fig. 4C shows an
unambiguous increase in Bcl-2 phosphorylation upon treat-
ment with Taxol (detectable after 3 h of treatment) and 10-Fig. 4. (A) Phosphorylation status of ERK, Raf, p38 and Caveolin-1:
Cellular protein (40 lg) per lane from HeLa cells for Control, (lane 1),
DMSO (solvent control, lane 2), Taxol 5 lM (lane 3), 10-DAB (lane 4)
and BacIII (lane 5) were treated for 1 h subjected to immunoblotting as
described materials and methods. Various panels indicate the phos-
phorylation status of kinases indicated. (B) Upper Panel): Total
phosphotyrosine content of HeLa cells upon Taxol treatment: Lane 1:
Untreated cells, Lane 2: DMSO solvent control; Lane 3: Taxol 5lM
for 5 min; Lane 4: Taxol 5 lM for 30 min; Lane 5: Taxol 5 lM for
60 min. Middle panel: Changes in the amount of phosphorylated
Caveolin-1. Bottom panel: Total Caveolin-1. (C) Phosphorylation
status of Bcl-2: Cellular protein (80 lg) per lane of HeLa cells treated
with Taxol (top panel), 10-DAB (middle) and BacIII (bottom panel)
5 lM each for 1–12 h and probed with anti-Bcl-2 antibody. Data are
one representative panel of four independent experiments.
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24 h may result in mild phosphorylation; see Ref. [3]).
Taxol is well known to stabilize the microtubules and also it
has a higher aﬃnity for microtubules than 10-DAB and BacIII
[14,15,2]. It has also been shown that the Caveolin-1 move-
ment is microtubule dependent [16]. Since we have observed
a dramatic change in caveolae movement, we examined the
overall microtubule networks by Confocal microscopy. We
could not ﬁnd any diﬀerence in the direct association between
GFP-Caveolin-1 and microtubules in the control and Taxol or
10-DAB or BacIII treated HeLa cells (Fig. 5A). However,
Nocodozole, which is known to inhibit polymerization of
microtubules, has increased the cell surface recruitment of
GFP-Caveolin-1. Interestingly enough, the recruitment in-
creases with time (see Fig. 5B) with little or no signiﬁcant
change in the dynamics of GFP-Caveolin-1. Based on the
observations of Taxol, 10-DAB and Nocodozole treatments,Fig. 5. (A) Eﬀect of drugs on association with GFP-Caveolin-1 with micro
coverslip and processed for Confocal imaging. Cells treated with DMSO (vec
were then ﬁxed and labeled with anti-a-Tubulin antibody to stain microtubul
staining (DAPI), green panel shows the distribution pattern of GFP-Caveolin
last panel. Data are one representative panel of three independent experiment
of after Nocodozole treatment: Distribution pattern of GFP-Caveolin-1 at t
recorded by TIRF microscope. Still frame images from the videos showin
Nocodozole (200 nM) at indicated times. TIRFM videos were acquired as
independent experiments. (C) TIRF images of GFP-Caveolin-1 on HeLa cel
HeLa cells were treated with EGF (70 nM) and the videos were acquired as
second. Images a–c, respectively represent GFP-Caveolin-1 before, after 10 m
of three independent experiments. (D) TIRF images of Taxol treated Cav-
transfected HeLa cells were treated with Taxol (5 lM) and the videos were
second. Panels a–c represent the images of the GFP-Caveolin-1 (D91–93) befo
Taxol. Data are one representative panel of three independent experiments.it is possible that the K&R dynamics of caveolae may be
dependent on microtubule dynamics.
Considering the diﬀerences in the dynamics ofGFP-Caveolin-
1, cytotoxicity and phosphorylation states of Raf-1, ERK1/2
and Bcl-2, it is clear that the observed diﬀerences are due to
the diﬀerence in the side chains, as Taxol, 10-DAB and BacIII
have the similar backbone. The K&R dynamics of caveolae, in
response to EGF (70 nM), exhibit cell surfacewithdrawal within
10 min (see video SV6 and SV7; before EGF treatment video
SV6, after 10 min of EGF treatment video SV7) and reappear-
ance after about 40–45 min after treatment (see video SV8 and
Fig. 5C panels a–c; longer periods of observation are not possi-
ble in TIRF microscope due to movement of basal membrane
away from cover slip as a result of EGF treatment associated cell
rounding). It has been shown that the Caveolin-1 is phosphory-
lated immediately after addition of EGF and may be dephos-
phorylated (likely) as it re-appears at the cell surface. Intubules: HeLa transiently expressing GFP-Caveolin-1 were plated on
tor control), Taxol (5 lM), 10-DAB (5 lM) and BacIII (5 lM) for 1 h
es and secondary antibody was Alexa-568. Blue panel show the nucleus
-1, red panel is the microtubule staining. Merged image is shown in the
s. (B) TIRF images of GFP-Caveolin-1 on HeLa cell basal membranes
he basal cell surface of the live HeLa cells after Nocodozole treatment
g the distributions of GFP-Caveolin-1 before and after treatment of
described for Fig 2A. Data, shown in all panels, is one of the three
l basal membranes upon EGF treatment: GFP-Caveolin-1 transfected
described for Taxol in Fig. 2. The video frame rate was 23 frames per
in and 40 min treatment with EGF. Data are one representative panel
1(D91-93)-GFP on HeLa cell basal membranes: Cav-1(D91–93)-GFP
acquired as described above. The video frame rate was 25 frames per
re, at 0 min (immediately after addition) and after 60 min of addition of
3600 N. Ahmed et al. / FEBS Letters 582 (2008) 3595–3600contrast, Taxol treatment results in withdrawal and sustained
phosphorylation of Caveolin-1. Thus, it appears that this sus-
tained phosphorylation of Caveolin-1 may be necessary for the
induction of apoptosis [4]. In sharp contrast, 10-DAB induces
phosphorylation of Caveolin-1 but for apoptosis; higher con-
centrations and/or longer times are needed. We speculate that
the rapid movement (of caveolae) is likely due to non-eﬃcient
recruitment of Raf-1 or other important molecules to the caveo-
lae aswe could not detect theRaf-1 at cellmembrane (samemag-
nitude that of Taxol) upon exposure of cells to 10-DAB and
BacIII (data not shown).
It is widely known that Taxol binds to Tubulin very tightly
[17]. In addition, it has been shown by molecular modeling that
the Taxol and BacIII can bind to Bcl-2 with the help of their
backbone [9]. However, there is no direct evidence of interaction
betweenTaxol andCaveolin-1, since Taxol, BacIII and 10-DAB
show distinct dynamics ofGFP-Caveolin-1, it may be likely that
the Taxol might recognize the sites of docking of caveolae vesi-
cles (K&R events) as we have consistently seen a dramatic in-
crease in the number clusters (high intensity spots in Fig. 2A,
V). It is also clear that in the absence of the side chain at car-
bon-13 of Taxol such cluster formation is completely absent.
Hence, the carbon-13 side chain of Taxol is mostly likely to
interact with the aromatic amino acids of Caveolin-1 (97YW-
FYRL102) which have been projected to insert into cytoplasmic
side of the cell membrane. In order to test this possibility, we
have deleted the amino acids 91–93 (91T-F-T93; as seen incase
of Caveolin-3 of Limb girdle muscular dystrophy-1C) of Cave-
olin-1 which has defective K&R dynamics as the caveolae re-
main docked to cell membrane at large (see Fig. 5D, panel a
and video SV9: before Taxol treatment). Interestingly, upon
Taxol treatment, we could not detect cell surface recruitment
of GFP-Cav-1(D91–93) and an immediate cluster formation of
GFP-Caveolin-1(D91–93) (see Fig. 5D, panel b). Moreover, there
was no signiﬁcant internalization of GFP-Caveolin-1(D91–93)
after 1 h of taxol (5lM) treatment either as seen from the TIRF
images (Fig. 5D, panel c and video SV10). One possible reason
for the cell surface recruitment of Caveolin-1 by Taxol could be
that the caveolae vesicles may get loaded with Taxol after
recruitment which are subsequently internalized (phosphoryla-
tion and internalization of Caveolin-1) for which the side chain
of Taxol plays an important role. To the best of our knowledge,
this is the ﬁrst report describing the changes in the dynamics of
caveolae elicited by the side chains of Taxol. Thismodel will help
us in understanding not only the signiﬁcance of the side chains of
Taxol, but also the role of caveolae vesicles for the development
of resistance in certain cancers to Taxol.
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